Aspects of medical and social rehabilitation of patients with essential hypertension

Sergey Nikiforovich Puzin; Marina Arsen’evna Shurgaya; Sevda Aydynovna Chandirli; Ol’ga Taymurazovna Bogova; Vladimir Nikolaevich Potapov; G. M Tairov

doi:10.17816/MSER35763

Medical and Social Expert Evaluation and Rehabilitation ›› 2014, Vol. 17 ›› Issue (1) : 10 -15. DOI: 10.17816/MSER35763

Articles

research-article

Aspects of medical and social rehabilitation of patients with essential hypertension

Author information +

History +

PDF

Abstract

Morbidity, disability and mortality from cardiovascular disease (CVD) have been steadily growing from year to year around the world. Essential hypertension (EH) is the leading cause in the structure of cardiovascular disease. In Russia EH is recorded in 30% of the adult population, and the annual death rate from EH and its complications is more than 1,5 million people. Clinical studies show that there is a close connection between blood pressure and cardiovascular events (acute myocardial infarction, cerebral stroke, cardiac arrhythmias, renal failure). Complications of hypertension are major causes of morbidity with temporary disability, are one of the leading causes of disability and premature death (high mortality). Effective rehabilitation for hypertension requires individualization of therapy, determination of the disease the stage and the degree of organ dysfunction and prediction of potential cardiovascular complications risk. The most effective method of hypertension control is an individualized regular medical therapy in combination with non-drug treatments.

Keywords

hypertension / risk factors for cardiovascular complications / morbidity / disability / mortality / rehabilitation

Cite this article

Download citation ▾

Sergey Nikiforovich Puzin, Marina Arsen’evna Shurgaya, Sevda Aydynovna Chandirli, Ol’ga Taymurazovna Bogova, Vladimir Nikolaevich Potapov, G. M Tairov. Aspects of medical and social rehabilitation of patients with essential hypertension. Medical and Social Expert Evaluation and Rehabilitation, 2014, 17(1): 10-15 DOI:10.17816/MSER35763

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Доклад о состоянии здравоохранения в Европе, 2009 г. Здоровье и системы здравоохранения. Копенгаген: ЕРБ ВОЗ; 2010.

[2]

Заболеваемость всего населения России в 2011 г. (статистические материалы). М.: Министерство здравоохранения Российской Федерации, Департамент анализа, прогноза, развития здравоохранения и медицинской науки, ФГУ Центральный научно-исследовательский институт организации и информатизации здравоохранения Минздрава; 2012; ч. 1, 3, 5.

[3]	Доклад ВОЗ «Инвалидность в мире» 2011 года.

[4]	Suhrcke M., Rocco L., McKee M. et al. (eds) on be half of the European Observatory on Health Systems and Policies. Economic consequences of noncommunicable diseases and injuries in the Russian Federation. WHO; 2007: 89.

[5]	Оганов Р.Г., Тимофеева Т.Н., Колтунов И.Е. и др. Эпидемиология артериальной гипертонии в России. Результаты федерального мониторинга 2003-2010 гг Кардиоваскулярная терапия и профилактика. 2011; 10(1): 8-12.

[6]	European Society of Cardiology. CVD Prevention in clinical practice (European guidelines on). 2007.

[7]	Оганов Р.Г., ред. Национальные клинические рекомендации: Сборник. 2-е изд. М.: Издательство «Силицея-Полиграф»; 2009.

[8]	Sanoski C.A., Pharm D. Aliskiren: an oral rennin inhibitor for the treatment of hypertension. Pharmacotherapy. 2009; 29: 193-212.

[9]	DiBona G.F., EslerM.Translational medicine: the antihypertensive effect of renal denervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010; 298: R245-53.

[10]	Постановление Правительства РФ от 28.12.2012 N 1472 «О внесении изменений в федеральную целевую программу «Предупреждение и борьба с социально значимыми заболеваниями (2007-2012 годы)»». М.; 2012.